ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,065 filers reported holding ASTRAZENECA PLC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,015,574 | +15.3% | 25,844 | +0.1% | 0.02% | +18.8% |
Q1 2024 | $1,748,628 | -6.3% | 25,810 | -6.8% | 0.02% | -20.0% |
Q4 2023 | $1,865,258 | -5.7% | 27,695 | -5.1% | 0.02% | -13.0% |
Q3 2023 | $1,977,085 | -20.6% | 29,195 | -16.1% | 0.02% | -11.5% |
Q2 2023 | $2,490,779 | +5.3% | 34,802 | +2.1% | 0.03% | -3.7% |
Q1 2023 | $2,365,215 | +111361.6% | 34,076 | +8.9% | 0.03% | 0.0% |
Q4 2022 | $2,122 | -99.9% | 31,302 | -0.6% | 0.03% | +3.8% |
Q3 2022 | $1,727,000 | -18.3% | 31,483 | -1.6% | 0.03% | -18.8% |
Q2 2022 | $2,114,000 | +24.3% | 31,998 | +24.8% | 0.03% | +60.0% |
Q1 2022 | $1,701,000 | +6.8% | 25,644 | -6.2% | 0.02% | +5.3% |
Q4 2021 | $1,592,000 | -3.0% | 27,336 | +0.1% | 0.02% | -5.0% |
Q3 2021 | $1,641,000 | +5.3% | 27,320 | +5.0% | 0.02% | +5.3% |
Q2 2021 | $1,559,000 | +18.9% | 26,028 | -1.3% | 0.02% | +11.8% |
Q1 2021 | $1,311,000 | -4.9% | 26,359 | -4.4% | 0.02% | -5.6% |
Q4 2020 | $1,379,000 | -9.8% | 27,580 | -1.1% | 0.02% | -25.0% |
Q3 2020 | $1,528,000 | +6.6% | 27,882 | +2.9% | 0.02% | -4.0% |
Q2 2020 | $1,434,000 | +25.8% | 27,107 | +6.2% | 0.02% | +8.7% |
Q1 2020 | $1,140,000 | +0.3% | 25,535 | +12.0% | 0.02% | +27.8% |
Q4 2019 | $1,137,000 | +8.7% | 22,801 | -2.8% | 0.02% | +12.5% |
Q3 2019 | $1,046,000 | +14.7% | 23,468 | +6.2% | 0.02% | +14.3% |
Q2 2019 | $912,000 | +4.6% | 22,103 | +2.4% | 0.01% | 0.0% |
Q1 2019 | $872,000 | -16.7% | 21,576 | -21.7% | 0.01% | -33.3% |
Q4 2018 | $1,047,000 | -0.6% | 27,566 | +3.6% | 0.02% | +10.5% |
Q3 2018 | $1,053,000 | +19.4% | 26,606 | +5.9% | 0.02% | +11.8% |
Q2 2018 | $882,000 | +53.4% | 25,120 | +52.7% | 0.02% | +54.5% |
Q1 2018 | $575,000 | +9.3% | 16,450 | +8.5% | 0.01% | 0.0% |
Q4 2017 | $526,000 | +77.7% | 15,164 | +73.8% | 0.01% | +83.3% |
Q3 2017 | $296,000 | -26.4% | 8,724 | -26.1% | 0.01% | -33.3% |
Q2 2017 | $402,000 | – | 11,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |